QbD Steered Development and Validation of UPLC/MS Method with a Comprehensive FMEA Risk Assessment to Quantify the Degradation Impurities of Posaconazole from Tablet Formulation and Their Pathways
Chromatographia · 2026-06 · 89 (4) · 405-418
DOI: 10.1007/s10337-026-04482-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chromatographia, online erschienen am 24.04.2026. Verfasst von Surajkumar D. Jadhav und 1 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Jadhav, S. D., & Wadher, S. (2026). QbD Steered Development and Validation of UPLC/MS Method with a Comprehensive FMEA Risk Assessment to Quantify the Degradation Impurities of Posaconazole from Tablet Formulation and Their Pathways. Chromatographia, 89(4), 405-418. https://doi.org/10.1007/s10337-026-04482-3
Vancouver
Jadhav SD, Wadher S. QbD Steered Development and Validation of UPLC/MS Method with a Comprehensive FMEA Risk Assessment to Quantify the Degradation Impurities of Posaconazole from Tablet Formulation and Their Pathways. Chromatographia. 2026;89(4):405-418. doi:10.1007/s10337-026-04482-3
BibTeX
@article{Jadhav2026,
author = {Jadhav, Surajkumar D. and Wadher, Shailesh},
title = {QbD Steered Development and Validation of UPLC/MS Method with a Comprehensive FMEA Risk Assessment to Quantify the Degradation Impurities of Posaconazole from Tablet Formulation and Their Pathways},
journal = {Chromatographia},
year = {2026},
volume = {89},
number = {4},
pages = {405--418},
doi = {10.1007/s10337-026-04482-3}
}
EUVIMED